Older adults on several blood pressure pills faced more fainting and dizziness in the first months after starting a GLP-1.
Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has helped boost its market capitalization to around $650 billion. Over the ...
Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results